Recombinant protein is a manipulated form of protein encoded by a gene called recombinant DNA. It produces large quantities of proteins and induces modify gene sequences and also incorporate to manufacture useful commercial products. The specialized vehicle responsible for the formation of recombinant protein is basically known as vectors and the process involved in the formation of recombinant protein is called as recombinant technology. The recombinant protein is widely used in enzyme activity assay, in-vitro diagnosis, antibody preparation, in-vivo efficacy evaluation and vaccine screening.
A full report of Recombinant Proteins Market is available at: https://www.omrglobal.com/industry-reports/recombinant-proteins-market
The global recombinant proteins market was valued $1.0B in year 2021 and was projected to reach $1.7B by 2027 with a magnificent CAGR of 9.8% during the forecast period 2021-2027. The growth of global recombinant proteins market was initially driven by the increasing government investments and R&D expenditure in pharmaceutical and biotechnological companies. As the R&D sector and its investment will occupy foremost position in global expenditure, it will intensify the growth of market by expanding their investment in pharmaceutical and biotechnological companies.
The market is segmented based on product type, application, and end user. Depending on the product type, global recombinant proteins market is segmented into Growth factors and Chemokines, Immune Response Proteins, Structural Proteins, Membrane Proteins, kinase Proteins, Regulatory Proteins, Recombinant Metabolic Enzymes, Adhesion Molecules & receptors respectively. Among these, growth factors and chemokines segment registered highest revenue shares in 2020. This growth is attributed to its broad application in various research areas such as neurobiology, immunology, wound healing, chemotaxis, cell culture, HIV/AIDS, stem cell and COVID-19 research.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/recombinant-proteins-market
Along with this, based on the application segment, the drug discovery and development expected to witness the substantial growth of the global recombinant proteins market during the forecast period. Due to its application in cell & genes therapy, vaccines, and biologics, the biologics department is expected to surge the growth of the global market.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Product Type
o By Application
o By End-User
- Competitive Landscape- Thermo Fisher Scientific inc., R&D Systems, Abcam plc, Merk KGaA, and Proteintech Group.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Recombinant proteins Market Report Segment
By Product Type
- Growth Factors and Chemokines
- Immune Response Proteins
- Structural Proteins
- Membrane Proteins
- Kinasa proteins
- Regulatory Proteins
- Recombinant Metabolic Enzymes
- Adhesion Molecules and Receptor
- Others
By Application
- Drug Discovery & Development
- Biopharmaceutical Production
- Biotechnology Research
- Academic Research studies
- Others
By End-User
- Pharmaceutical and Biopharmaceutical Companies
- Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Others
This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.
